Highlights Healthcare personnel are at risk for nosocomial acquisition of COVID-19. We evaluated the exposure history of hospital personnel with COVID-19. Twenty-five percent of personnel with COVID-19 were exposed to an infected patient or co-worker. Exposure to infected co-workers occurred in nonpatient care settings. Fourteen percent of personnel with COVID-19 were exposed in the community.
Several recent reports have raised concern that infected co-workers may be an important source of SARS-CoV-2 acquisition by healthcare personnel. In a suspected outbreak among emergency department personnel, sequencing of SARS-CoV-2 confirmed transmission among co-workers. The suspected 6-person outbreak included 2 distinct transmission clusters and 1 unrelated infection.
Background Healthcare personnel and patients are at risk to acquire severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in healthcare settings, including in outpatient clinics and ancillary care areas. Methods Between May 1, 2020 and January 31, 2021, we identified clusters of 3 or more COVID-19 cases in which nosocomial transmission was suspected in a Veterans Affairs healthcare system. Asymptomatic employees and patients were tested for SARS-CoV-2 if they were identified as being at risk through contact tracing investigations; for 7 clusters all personnel and/or patients in a shared work area were tested regardless of exposure history. Whole genome sequencing was performed to determine the relatedness of SARS-CoV-2 samples from the clusters and from control employees and patients. Results Of 14 clusters investigated, 7 occurred in community-based outpatient clinics, 1 in the emergency department, 3 in ancillary care areas, and 3 on hospital medical/surgical wards that did not provide care for patients with known COVID-19 infection. Eighty-one of 82 (99%) symptomatic COVID-19 cases and 31 of 35 (89%) asymptomatic cases occurred in healthcare personnel. Sequencing analysis provided support for several transmission events between co-workers and in 2 cases supported transmission from healthcare personnel to patients. There were no documented transmissions from patients to personnel. Conclusions Clusters of COVID-19 with nosocomial transmission predominantly involved healthcare personnel and often occurred in outpatient clinics and ancillary care areas. There is a need for improved measures to prevent transmission of SARS-CoV-2 by healthcare personnel in inpatient and outpatient settings.
Background This study aimed to determine the impact of pulmonary complications on death after surgery both before and during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Methods This was a patient-level, comparative analysis of two, international prospective cohort studies: one before the pandemic (January–October 2019) and the second during the SARS-CoV-2 pandemic (local emergence of COVID-19 up to 19 April 2020). Both included patients undergoing elective resection of an intra-abdominal cancer with curative intent across five surgical oncology disciplines. Patient selection and rates of 30-day postoperative pulmonary complications were compared. The primary outcome was 30-day postoperative mortality. Mediation analysis using a natural-effects model was used to estimate the proportion of deaths during the pandemic attributable to SARS-CoV-2 infection. Results This study included 7402 patients from 50 countries; 3031 (40.9 per cent) underwent surgery before and 4371 (59.1 per cent) during the pandemic. Overall, 4.3 per cent (187 of 4371) developed postoperative SARS-CoV-2 in the pandemic cohort. The pulmonary complication rate was similar (7.1 per cent (216 of 3031) versus 6.3 per cent (274 of 4371); P = 0.158) but the mortality rate was significantly higher (0.7 per cent (20 of 3031) versus 2.0 per cent (87 of 4371); P < 0.001) among patients who had surgery during the pandemic. The adjusted odds of death were higher during than before the pandemic (odds ratio (OR) 2.72, 95 per cent c.i. 1.58 to 4.67; P < 0.001). In mediation analysis, 54.8 per cent of excess postoperative deaths during the pandemic were estimated to be attributable to SARS-CoV-2 (OR 1.73, 1.40 to 2.13; P < 0.001). Conclusion Although providers may have selected patients with a lower risk profile for surgery during the pandemic, this did not mitigate the likelihood of death through SARS-CoV-2 infection. Care providers must act urgently to protect surgical patients from SARS-CoV-2 infection.
HCW had no other known COVID-19 exposures but did interact unmasked with coworkers in the 2 weeks before testing positive. Whole-genome sequencing detected the SARS-CoV-2 delta variant (B.1.617.2). Genome alignment to 41 other delta variants isolated at our institution from April through July 2021 confirmed the relatedness of the 2 HCW viruses and their distinctiveness from other SARS-CoV-2 isolates (Fig. 1). DiscussionRecent CDC guidance says that fully vaccinated individuals may not need to wear masks indoors or practice physical distancing due to vaccine effectiveness and the low likelihood of a fully vaccinated person transmitting the virus to others. 4 The genetic and epidemiological data from our investigation of 2 HCW with breakthrough SARS-CoV-2 infection strongly suggest transmission of the SARS-CoV-2 virus delta variant from one fully vaccinated individual to another in the setting of unmasked close contact. Limitations include the fact that source of the infection for the first HCW is unknown; it remains possible that both HCWs were infected with SARS-CoV-2 from a common source or through separate exposures.SARS-CoV-2 variants, such as the delta variant, can have higher viral loads, potentially increasing transmissibility and requiring enhanced public health measures. 5 This apparent transmission of SARS-CoV-2 from one fully vaccinated person to another demonstrates that masking and physical distancing remain vital infection prevention measures for fully vaccinated people while the SARS-CoV-2 virus is still evolving and circulating.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.